Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pseudobulbar Affect (PBA)”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Large-scale testing (Phase 3)Study completedNCT00573443
What this trial is testing

Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS

Who this might be right for
Pseudobulbar Affect (PBA)
Avanir Pharmaceuticals 326
Post-approval studies (Phase 4)Ended earlyNCT01832350
What this trial is testing

Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseasePseudobulbar Affect (PBA)
St. Joseph's Hospital and Medical Center, Phoenix 34
Post-approval studies (Phase 4)Study completedNCT01799941
What this trial is testing

Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA)

Who this might be right for
Pseudobulbar Affect (PBA)StrokeDementia+1 more
Avanir Pharmaceuticals 367
Post-approval studies (Phase 4)Ended earlyNCT02496039
What this trial is testing

Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With Pseudobulbar Affect (PBA)

Who this might be right for
Pseudobulbar Affect (Involuntary Laughing and/or Crying)
Avanir Pharmaceuticals 5